Tag: Aaron Gu
Lawyers analyse China’s drug trial data protection rules
China’s new drug trial data protection rules are considered a boost for development, but some lawyers warn disputes may arise
Han Kun, Zhong Lun act on Sino Biopharm’s USD950m LaNova buy
Han Kun and Zhong Lun advised on Sino Biopharm’s USD950m acquisition of cancer drugmaker LaNova Medicines
The A-List 2024-25: Rising Stars
When helping clients navigate a complex legal landscape, young elite lawyers have brought fresh ideas and innovative approaches to the table





















